Popular on Amzeal
- Industrial & systems engineering educator and professional to lead global strategic partnerships for professional society - 380
- Make this classic claw game your next amusement machine - 291
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX - 263
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 248
- Novastart Launches the Infinite Canvas OS, Where AI Agents Work in Plain Sight - 242
- Network Services Group Highlights Essential IT Support Services for Cybersecurity Awareness Month - 239
- Acuvance Survey Finds ERP Integration Remains a Key Challenge as Healthcare Organizations Prepare for AI - 226
- Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era - 221
- ESPEC North America Brings Integrated Semiconductor Reliability Testing to SEMICON West 2026 - 217
- Personal Prompt Builder™ App Launches With Free Prompt Generation for a Quick Start - 190
Similar on Amzeal
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
- Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
- New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
Peer-Reviewed Study Shows Measurable Impact on Employee Health and Productivity from Employee Assistance Program
Amzeal News/10488550
Five-year longitudinal analysis finds 84 percent of employees with depression and 78 percent with alcohol use concerns migrated to low- or no-risk after EAP treatment.
CHICAGO - Amzeal -- To many employers, the value of an employee assistance program (EAP) is based on the understanding that employees with unresolved mental health, substance use and emotional wellbeing concerns often have troubles in their professional and personal lives that ultimately impact the organization's bottom line. Historically, EAPs and other workplace mental health providers have used a variety of metrics to illustrate their ability to resolve or mitigate these concerns, such as employee utilization, referrals to external resources, satisfaction surveys or website usage. While these measurements are effective and valuable tools that help employers evaluate the reach of the program, they don't truly measure the impact of the program on employee health, wellbeing and productivity.
New research published in the International Journal of Scientific and Research Publications (Volume 12, Issue 8, August 2022) reinforces how CuraLinc's unique approach to workplace mental health drives meaningful and lasting behavior change that leads to a decrease in absenteeism, an increase in productivity and improved health outcomes for employees who present with depression or alcohol use.
Depression
The aforementioned results were an excerpt from a peer-reviewed analysis of 33,683 EAP cases that originated between July 2017 and June 2022. Although data was collected from all participants, including spouses and dependents, only results from covered employees of CuraLinc clients were used in the data set.
More on Amzeal News
CuraLinc used the following clinically validated instruments to measure data from EAP participants.
CuraLinc offered the SPS-6 and WOS to all employees; and offered the PHQ-9 and AUDIT to employees who presented with depression and alcohol abuse, respectively. After the assessment, CuraLinc followed up at the 30-day mark to measure changes in the employee's health and productivity, as well as their satisfaction with the EAP.
"Of the metrics available to help employers evaluate a workplace mental health program, one group stands above the rest – health and productivity outcomes," said CuraLinc's Senior Vice President of Administration, David Pawlowski, LCPC, CEAP, SAP. "Year after year, our program drives positive and measurable outcomes that impact not only job performance, but also the overall quality of life for employees who use the program."
About CuraLinc Healthcare
CuraLinc Healthcare, headquartered in Chicago, provides transformative mental health care fueled by connectivity – marrying technology and personalized advocacy to engage, empower and support employees throughout their care journey. For more information, please call 800.490.1585, email info@curalinc.com or visit curalinc.com. Additional details regarding this study can also be found at IJSRP.org and at EAPOutcomes.com.
More on Amzeal News
New research published in the International Journal of Scientific and Research Publications (Volume 12, Issue 8, August 2022) reinforces how CuraLinc's unique approach to workplace mental health drives meaningful and lasting behavior change that leads to a decrease in absenteeism, an increase in productivity and improved health outcomes for employees who present with depression or alcohol use.
Depression
- 84% of employees with depression recovered after EAP treatment to no longer be at-risk.
- Only 12% of participants with depression were in a high-risk range after using the EAP, compared to 60% prior to participating in the program.
- 34% of participants had a work productivity problem prior to using the EAP, dropping to 5% after treatment.
- Seven out of eight at-risk cases (88%) recovered to no longer have a work productivity problem after using the program.
- The average time missed from work due to the employee's presenting concern dropped from 9.0 hours during the initial assessment to 1.8 hours after using the program.
- Half of EAP users (51%) had zero absences during the month before starting counseling, rising to 91% after completing treatment.
- At the start of counseling, 66% of employees who presented with alcohol use as a primary or secondary concern were initially classified as risky drinkers or at a more severe level of alcohol misuse, but after counseling, only 14% of cases were at-risk.
- After EAP treatment, 86% of employees were no longer at risk for alcohol misuse.
The aforementioned results were an excerpt from a peer-reviewed analysis of 33,683 EAP cases that originated between July 2017 and June 2022. Although data was collected from all participants, including spouses and dependents, only results from covered employees of CuraLinc clients were used in the data set.
More on Amzeal News
- ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
- Atomic Clocks Go Strategic: Defense, SATCOM, 5G/6G Transition and AI Drive Precision Timing
- Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- Cherry Master parts help your machines function at a high level
CuraLinc used the following clinically validated instruments to measure data from EAP participants.
- Stanford Presenteeism Scale (SPS-6): Productivity
- Workplace Outcomes Suite (WOS): Absenteeism
- Patient Health Questionnaire (PHQ-9): Depression
- Alcohol Use Disorders Identification Test (AUDIT): Alcohol Use
CuraLinc offered the SPS-6 and WOS to all employees; and offered the PHQ-9 and AUDIT to employees who presented with depression and alcohol abuse, respectively. After the assessment, CuraLinc followed up at the 30-day mark to measure changes in the employee's health and productivity, as well as their satisfaction with the EAP.
"Of the metrics available to help employers evaluate a workplace mental health program, one group stands above the rest – health and productivity outcomes," said CuraLinc's Senior Vice President of Administration, David Pawlowski, LCPC, CEAP, SAP. "Year after year, our program drives positive and measurable outcomes that impact not only job performance, but also the overall quality of life for employees who use the program."
About CuraLinc Healthcare
CuraLinc Healthcare, headquartered in Chicago, provides transformative mental health care fueled by connectivity – marrying technology and personalized advocacy to engage, empower and support employees throughout their care journey. For more information, please call 800.490.1585, email info@curalinc.com or visit curalinc.com. Additional details regarding this study can also be found at IJSRP.org and at EAPOutcomes.com.
More on Amzeal News
- Understanding COP and EER Ratings Helps Victorian Homeowners Compare Hot Water Heat Pumps
- SLYNUMBER Gives Consumers More Confidence in Financial Texts with Verified Origination
- The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
- Gen-Z Entrepreneur Darian Crisp Launches CineTank Kickstarter Campaign to Transform Mobile Film P
- Mushroom supplements and therapeutic application
Source: CuraLinc Healthcare
0 Comments
Latest on Amzeal News
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
- How Melbourne's Changing Climate Impacts Solar Battery Efficiency, Performance and Lifespan
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Haptic Zones Zone Playground Lets Anyone Draw a Zone and Watch Compliance Code Appear
- Nexorumi Pty Ltd Launches in Australia with Focus on AI Infrastructure
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
- The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
- Choosing the Right Heating System for Your Home: A Comprehensive Guide
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- Arizona Technology Council and Arizona Commerce Authority Announce 2026 GCOI Legislator Award Honorees
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
- Integrative Systems Applies AI to IBM i Modernization While Preserving Critical Business Logic
- Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
- Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
- PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
- GlucoPredict™ Prepares for Second Pilot of Meal and Portion Education Platform
- KOLBUS America, For All Of Your Hycorr Equipment And Service Needs

